And I missed OCC - Orthocell. Most in here are aware of it anyway. Announced that they now have 12 distributors in the US, ahead of schedule (aimed to have 10 by the end of June). First sales of Remplir in the US are imminent. SP on a downtrend, possibly because of Trumpy's medical tariffs, or maybe because traders have moved on. Dunno. Anyhow, news on the threads is that they have just been approved to sell Remplir in Hong Kong so this announcement should be on Monday. With US sales imminent plus a TGA SmrtGraft approval due within a month (around June 11), there is still good news on the horizon. Market cap around $334m. I do hold and also have trade parcels on this one.
